Stage 1 kidney cancer — what it means, and what happens next
A stage 1 report means the tumour measures 7 cm or less and has stayed inside the kidney — nothing in the lymph nodes, nothing anywhere else. Written out in the staging system it is T1 N0 M0, and it is split into 1a and 1b at the 4 cm mark. This page stays with that one stage: what those letters describe, what they deliberately do not describe, what is usually discussed at this point, and what your outlook really turns on. It is the most curable stage of kidney cancer, and the whole conversation is about keeping it that way while preserving as much working kidney as possible.
- Contained, and under 7 cm — Stage 1 is a statement about size and containment only. The tumour has not grown through the kidney’s outer layer, has not entered a major vein, and has not reached the lymph nodes or another organ.
- 1a and 1b are separated at 4 cm — T1a is 4 cm or less; T1b is above 4 cm and up to 7 cm. The line matters because it changes which options are usually on the table, not because the cancer becomes a different disease.
- Saving kidney is part of the plan — Wherever the tumour’s position allows it, removing the tumour and leaving the rest of the kidney behind is the aim. That surgery is coordinated for you with specialist urology and uro-oncology partners, where it may also be billed.
- Scans, review and follow-up in-house — CT, ultrasound, MRI, biopsy, blood work, genetic counselling, radiotherapy, surveillance monitoring and long-term follow-up are delivered in-house at CION, and every plan goes to a tumour board along NCCN lines.
on Panel
Telangana & AP
Treated
(800+ reviews)
What “stage 1” is actually telling you
Staging as a whole — how the T, N and M categories are assigned across every stage — is set out on our page on kidney cancer staging (TNM) explained. Our kidney cancer guide starts further back, with symptoms and diagnosis. This page stays with the one stage on your report and follows it step by step.
Stage answers one question: how far, not how bad
Staging measures distance travelled. It asks how large the tumour is, whether it has broken out of the kidney, whether it has reached the lymph nodes and whether it has appeared anywhere else. It does not ask how abnormal the cells look, how quickly they divide, or which subtype of kidney cancer this is. Those judgements are made separately by a pathologist and printed on their own lines. People often read stage 1 as a verdict on the whole report; it is one measurement out of several.
T1 means the kidney has held it in
Each kidney sits inside a fibrous capsule, wrapped in a layer of fat and enclosed again by a tougher sheet called Gerota’s fascia. T1 means the tumour is still within that packaging, and measures no more than 7 cm at its widest point. It has not grown into the surrounding fat, has not entered the renal vein or the vena cava, and has not reached the adrenal gland above the kidney. Radiologists look specifically for each of those things when they report a staging scan.
T1a and T1b: the same stage, split at 4 cm
T1a is a tumour of 4 cm or less. T1b is anything larger than 4 cm up to and including 7 cm. Both are stage 1 and both are confined to the kidney. The threshold exists because the options usually change around it: below 4 cm there is more room to remove the tumour alone, to destroy it with heat or cold, or to watch it carefully in someone for whom an operation carries real risk. Where exactly the tumour sits inside the kidney often matters as much as which side of 4 cm it falls.
N0 and M0: the two letters people skip past
N0 means no cancer was found in the lymph nodes near the kidney. M0 means no deposit was found in the lungs, bones, liver, brain or anywhere else. Together they are the reason stage 1 sits where it does. They come from the staging scans — a contrast CT of the abdomen and an assessment of the chest — which is why those scans are done before any decision is made, even when the kidney tumour itself looks small and straightforward. CT, ultrasound, MRI and the blood work that goes with them are delivered in-house at CION.
Most stage 1 tumours are found by accident
The kidneys sit deep and have room to accommodate a growth without complaint, so early kidney cancer rarely announces itself. A great many stage 1 tumours are picked up on an ultrasound or CT ordered for something else entirely — back pain, gallstones, a health check, an injury. That is worth knowing for two reasons. It explains why you may feel completely well while holding a cancer diagnosis, and it explains why the absence of symptoms tells you nothing about whether the finding needs acting on.
The stage is confirmed, then read with everything else
The stage on a scan report is a clinical stage, an informed estimate from imaging. If the tumour is removed, the pathologist restages it on the tissue itself and adds the grade, the subtype and whether the margin is clear. Those lines are read together at a tumour board, and the plan is built along NCCN lines from all of them rather than from the stage alone. What follows from there, and how it is costed and arranged, is set out on our kidney cancer treatment in Hyderabad page. Book a free consultation if you would like your own report read this way.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Early is the good news. Ask what the rest of the report says.
Our medical oncologists read the stage, the grade and the subtype together, take the case to a tumour board rather than one doctor’s opinion, and tell you plainly which options genuinely apply to you. Free first consultation, and no commitment to start treatment.
The options that belong to stage 1 — and how each is arranged
This is a map of the conversation, not a recommendation: which of these applies to you depends on where the tumour sits, your kidney function, your other illnesses and what the pathology shows. The right-hand column is deliberate — CION is a medical-oncology-led network, so some of what follows a stage 1 diagnosis is delivered in-house and some is coordinated for you with specialist partner centres, where it may also be billed.
| Option | Usually considered when | How it is arranged at CION |
|---|---|---|
| Partial nephrectomy (kidney-sparing surgery) |
The usual aim for a T1a tumour, and for a T1b tumour that sits in a position a surgeon can work around. Only the tumour and a rim of tissue are taken; the rest of the kidney stays and keeps working. | Coordinated with specialist urology and uro-oncology partners, including robotic and laparoscopic approaches, where the procedure may also be billed. |
| Radical nephrectomy | When the tumour’s position, its relation to the blood vessels or the collecting system, or its size within T1b makes sparing part of the kidney unsafe or incomplete. | Coordinated with the same specialist urology and uro-oncology partners. |
| Thermal ablation (radiofrequency or cryotherapy) |
Small T1a tumours, particularly where an anaesthetic or an operation carries extra risk, or where kidney function is already reduced. A needle is guided into the tumour and it is destroyed with heat or cold. | Coordinated with specialist interventional radiology partners, where it may also be billed. |
| Active surveillance | Small tumours — usually well within T1a — especially in older people or where other illnesses make an operation a bigger threat than the tumour. The tumour is measured on a set schedule and treated if it starts to grow. | In-house. The scans, the interval reviews and the decision on when to intervene are run by CION. |
| Needle biopsy before deciding | Where the plan is ablation or surveillance, where the imaging is not clear-cut, or where knowing the subtype and grade first would change the decision. | In-house — biopsy, pathology review and a second read of outside slides. |
| Stereotactic radiotherapy (SBRT) | Selected people who cannot safely have surgery or ablation. Highly focused radiation is delivered to the tumour over a small number of sessions. | In-house, planned with CION radiation oncologists. |
| Drug treatment after surgery | Not routine at stage 1. NCCN guidance reserves treatment after surgery for resected disease judged to carry a higher risk of returning, which stage 1 usually does not. | In-house if it is ever needed — systemic therapy at CION is medical-oncology led. |
| Follow-up surveillance | After any treatment. Scheduled imaging of the abdomen and chest plus blood tests including kidney function, on an interval set from the grade, the subtype and what was done. | In-house, including the survivorship and kidney-function side of it. |
Two of these have pages of their own: partial nephrectomy, the kidney-sparing operation explains what is removed and what is kept, and active surveillance for small kidney tumours explains who it suits and what the monitoring schedule looks like. If you want the whole route rather than one step of it, including how costs are explained in writing before anything begins, start with kidney cancer treatment in Hyderabad.
What the outlook at stage 1 really depends on
Stage 1 carries the best outlook of any stage of kidney cancer, because the disease has not left the organ it started in. But the stage is not the whole answer, and a percentage copied from a search result is not an answer at all. These are the things your own oncologist weighs.
Where you sit inside stage 1
A 2 cm tumour and a 6.5 cm tumour are both stage 1, and both are confined to the kidney, but they are not identical situations. Size is one input into how the tumour is treated and how closely you are followed afterwards. It is also the only thing separating T1a from T1b, which is why the measurement on your scan report is quoted so precisely.
How abnormal the cells look
Grade is assigned by a pathologist from the appearance of the tumour cell nuclei, on a scale from 1 to 4, and it is decided completely independently of stage. A small, contained tumour can still carry a high grade. Grade is one of the strongest influences on how intensively you are followed up after a stage 1 tumour is treated.
Which kidney cancer it is
Kidney cancer is a family, not a single disease. The subtype named on your pathology report — and whether features such as sarcomatoid change are mentioned alongside it — affects how a tumour tends to behave and what would be considered if it ever came back. At stage 1 it changes the follow-up conversation far more than it changes the immediate one.
Whether it came out completely
If the tumour is removed, the pathologist checks whether cancer reaches the cut edge of the specimen. A clear margin is the goal and is the usual result in planned surgery for a contained tumour. If the margin is not clear, that is not a catastrophe, but it does change the follow-up plan and is worth asking about directly rather than inferring from the report.
The function you keep
Outcome at stage 1 is not only about the cancer. Many people who develop kidney tumours also have diabetes or high blood pressure, and how much working kidney you keep affects your health for decades afterwards. That is the real argument for kidney-sparing surgery where it is feasible, and it is why kidney function is tracked at every follow-up visit, not just tumour size.
The schedule that protects the result
Kidney cancer can return years after successful treatment, so surveillance runs long. Keeping to the schedule of scans and blood tests is one of the few parts of the outlook you control directly. Between visits, tell your team about persistent bone pain, breathlessness, unexplained weight loss or blood in the urine rather than waiting for the next appointment.
Why there is no percentage on this page. Survival figures for stage 1 kidney cancer come from large registries gathered over many years, mostly in other health systems, and they average together every grade, every subtype and people of every age and level of general health. Quoting one of those averages back at you would look precise and mean very little about your own situation. Ask your oncologist for a figure that accounts for your grade, your subtype and your kidney function, and ask what it is based on — a specialist who has read your report can give you that context, and a web page cannot. Our kidney cancer treatment in Hyderabad page sets out how that discussion is structured at CION, and a free consultation is the fastest way to have it.
A contained tumour deserves an unhurried decision
Every case at CION goes to a tumour board, not one doctor’s opinion. If an option is being pushed that your report does not support, we will say so.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Questions people ask about stage 1 kidney cancer
What does stage 1 kidney cancer mean?
Stage 1 kidney cancer means the tumour is 7 cm or smaller in its longest measurement and has stayed inside the kidney. In the TNM system this is written T1 N0 M0: T1 for a contained tumour of up to 7 cm, N0 for no cancer found in the nearby lymph nodes, and M0 for no sign of spread to other organs. Nothing about the stage describes how abnormal the cells look down a microscope, how quickly the tumour grows, or which subtype of kidney cancer it is. Those are separate lines on the same report. Stage answers one question only, which is how far the cancer has travelled, and at stage 1 the answer is that it has not left the kidney.
What is the difference between stage 1a and stage 1b kidney cancer?
Both are still inside the kidney, and the only thing separating them is size. Stage 1a, written T1a, is a tumour of 4 cm or less. Stage 1b, written T1b, is larger than 4 cm but no more than 7 cm. The line is drawn at 4 cm for practical rather than biological reasons: it is the point at which the conversation about how to treat the tumour usually changes. Below it, removing the tumour and leaving the rest of the kidney behind is often straightforward, and thermal ablation or a period of monitoring may also be reasonable. Above it, kidney-sparing surgery is still the aim wherever the tumour sits in a workable position, but that depends more on where the tumour is than on its size alone.
Is stage 1 kidney cancer curable?
Stage 1 is the most curable stage of kidney cancer, and for most people the procedure that removes the tumour completely is the whole of the treatment. Drug therapy afterwards is not routine, because there is usually nothing left to treat. Curable is not the same as certain, though, and no honest oncologist will promise an outcome. What is fair to say is that a tumour caught while it is still inside the kidney puts you in the strongest position anyone with kidney cancer can be in, and that the plan at this stage is built around cure rather than control. Your own outlook still depends on the grade, the subtype, and whether the tumour was removed with a clear margin.
What is the survival rate for stage 1 kidney cancer?
We deliberately do not publish a survival percentage for stage 1 kidney cancer on this page. The figures quoted online come from large registries collected over many years, often in other health systems, and they average together tumours of different grades and subtypes in people of very different ages and general health. A number pulled from that average can mislead in either direction for one individual. What is true in general is that stage 1 carries the best outlook of any stage, because the cancer has not left the kidney. Ask your oncologist for a figure that takes your own grade, subtype and kidney function into account, and ask what it is based on.
Will I need chemotherapy or immunotherapy for stage 1 kidney cancer?
Usually not. Kidney cancer responds poorly to conventional chemotherapy, so it has no routine role at any stage. Immunotherapy and targeted therapy are central to advanced kidney cancer, but once a stage 1 tumour has been removed completely there is normally nothing left for them to act on, and NCCN guidance reserves treatment after surgery for people whose disease carried a higher risk of returning. Stage 1 sits below that threshold in most cases. What follows a stage 1 diagnosis instead is a surveillance schedule of scans and blood tests. If something changes, the discussion about systemic treatment happens then rather than now, and any drug-specific question is best put to a medical oncologist directly.
Can stage 1 kidney cancer come back after treatment?
It can, which is why follow-up runs for years rather than months, but the risk after a stage 1 tumour has been removed completely is low compared with every later stage. Recurrence is watched for with scheduled imaging of the abdomen and chest and with blood tests that include kidney function, on a schedule your team sets from the grade, the subtype and how the tumour was treated. Kidney cancer has a habit of returning late, sometimes many years afterwards, which is why the schedule is deliberately long. Report new symptoms between visits rather than waiting for the next scan, particularly persistent bone pain, breathlessness, unexplained weight loss or blood in the urine.
This page is general health information about one stage of kidney cancer. It is not a diagnosis, and it cannot replace a specialist review of your own scans, slides and report. Only a doctor who has seen your imaging and examined you can say which options apply to your tumour and what your stage means for you. If you have a report you do not understand, please arrange a review rather than waiting — and tell your team straight away about new bone pain, breathlessness, unexplained weight loss or blood in the urine, because those symptoms change what is looked at next.